Testing Therapeutic Potency of Anticancer Drugs in Animal Studies: A Commentary
Authors:
- Peter A. SteerenbergPSPeter A. Steerenberg
- Jan Willem Van der LaanJLJan Willem Van der Laan
- 30 April 2002
- journal article
- review article
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 35 (2) , 266-272
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Regulatory considerations for preclinical development of anticancer drugsCancer Chemotherapy and Pharmacology, 1997
- Azaserine-induced pancreatic carcinogenesis in rats: promotion by a diet rich in saturated fat and inhibition by a standard laboratory chowCancer Letters, 1990
- EORTC guidelines for phase I trials with single agents in adultsEuropean Journal of Cancer and Clinical Oncology, 1985
- Regression of Established Tumors and Induction of Tumor Immunity by Intratumor ChemotherapyJNCI: Journal of the National Cancer Institute, 1976
- 486. Aryl-2-halogenoalkylamines. Part XII. Some carboxylic derivatives of NN-di-2-chloroethylanilineJournal of the Chemical Society (Resumed), 1953
- MYLERAN IN CHRONIC MYELOID LEUKÆMIA CHEMICAL CONSTITUTION AND BIOLOGICAL ACTIONThe Lancet, 1953